[Antiphospholipid antibodies in high-risk pregnancy].

Unlabelled: Recently the connection of antiphospholipid antibodies (aPLs) presence with pregnancy loss and complications in pregnancy has been observed APLs related obstetric complications include: miscarriages after 10 weeks, IUGR, intrauterine foetal death, preeclampsia and severe preeclampsia. Our objective was to determine the aPLs prevalence in patients with recurrent pregnancy loss and/or complicated pregnancy. We examined 154 pregnant women aged 19-42 (average of 29.

Comparison of the effects of Salbupart and Partusisten on the serum levels of insulin, glucose, sodium and potassium in pregnant women.

The effect of tocolytic treatment with Salbupart and Partusisten in imminent premature labour on the serum levels of insulin, glucose, sodium and potassium was studied after 24 hours, and in some cases after 48 and 72 hours from the beginning of intravenous tocolytic treatment. The control group comprised healthy pregnant women receiving no tocolytic treatment. Statistical analysis showed that Salbupart and Partusisten raised the levels of insulin and glucose in the serum in pregnant women, but Salbupart increased more the insulin level and the raised levels of insulin and glucose persisted longer after Salbupart.